MedTrace Logo

Screening of the Possible Risk Factors for Borderline Personality Disorders and Validation of Maclean Instrument

NCT05831852 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-09-07

No results posted yet for this study

Summary

Borderline personality disorder is a mental illness that severely impacts a person's ability to regulate their emotions. This loss of emotional control can increase impulsivity, affect how a person feels about themselves, and negatively impact their relationships with others. In fact, the societal impact of BPDs might be found in emotional suffering, disability and economic burden. In addition in BPD, the suicide rate might be as high as 8-10%. the presence of BPD also interferes with response to treatment of physical and psychiatric comorbidities, such as migraine, HIV, anxiety disorders and substance use disorders. Furthermore, BPD in particular, are associated with high rates of unemployment, absences from work and inefficiency at work, with only 25% of patients suffering from BPD working full time and 40% receiving disability payments. Accordingly, early detection and management would be of great societal and economic impact. Our Study aim is to validate the Arabic version of Maclean Instrument for screening and detection of BPD and and investigate the possible risk factors associated with that disease

Conditions

  • Borderline Personality Disorder

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • October University for Modern Sciences and Arts

    lead OTHER

Principal Investigators

  • sara Eladawy, PhD · MSA university

  • mohamed hafez · biostatistician, biomedical informatics medical research institute Alexandria University

  • mohamed emad · biostatistician, biomedical informatics, medical research institute, Alexandria University

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-09-01
Completion
2023-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05831852 on ClinicalTrials.gov